Functional imaging and detection of local recurrence in soft tissue sarcomas by positron emission tomography

Anticancer Research

Volumn 19, Issue 2 B, 1999, Pages 1343-1349

  Schwarzbach, Matthias ^a   Willeke, Frank ^a   Dimitrakopoulou Strauss, Antonia ^b   Strauss, Ludwig G ^b   Zhang, Yu Min ^b   Mechtersheimer, Gunhild ^a   Hinz, Ulf ^a   Lehnert, Thomas ^a   Herfarth, Christian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Aminoisobutyric acid; Nuorodeoxyglucose; Oxygen labeled water; Positron emission tomography; Soft tissue sarcoma

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; CARBON 11; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; SOFT TISSUE SARCOMA;

ADULT; AGED; ANIMALS; CARBON RADIOISOTOPES; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; OXYGEN RADIOISOTOPES; RADIOPHARMACEUTICALS; SARCOMA; TOMOGRAPHY, EMISSION-COMPUTED; VASCULAR NEOPLASMS;

EID: 0033065772     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Enzinger FM, Weiss SW: Soft tissue tumors (ed 3). St. Louis, Missouri, Mosby 1-26, 1995.
2. Hicks RJ: Nuclear medicine techniques provide unique physiologic characterization of suspected and known soft tissue and bone sarcomas. Acta Orthop Scand 273(suppl): 25-36, 1997.
3. Coleman RE: Single photon emission computed tomography and positron emission tomography in cancer imaging. Cancer 67: 1261-1270, 1991.
4. Mitsuhashi N, Hayakawa K, Hasegawa M, Furuta M, Katano S, Sakurai H, Akimoto T, Takahashi T, Nasu S, Niibe H: Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor. Anticancer Res 18: 2827-2832, 1998.
5. Bender H, Kirst J, Palmedo H, Schomburg A, Wagner U, Ruhlmann J, Biersack HJ: Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Anticancer Res 17: 1687-1692, 1997.
6. Strauss LG: Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23: 1409-1415, 1996.
7. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, van Kaick G: Evaluation of tumor metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 22: 434-442, 1995.
8. Jabour BA, Choi Y, Hoh CK, Rege SD, Soong JC, Lufkin RB, Hanafee WN, Maddahi J, Chaiken L, Bailet J: Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 186: 27-35, 1993.
9. Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, al-Kaisi, Miraldi F: Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 32: 1508-1512, 1991.
10. Van Gingkel RJ, Hoekstra HJ, Pruim J, Nieweg OE, Molenaar WM, Paans AMJ, Willemsen AT, Vaalburg W, Koops HS: FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma. J Nucl Med 37: 984-990, 1996.
11. Jones DN, McCowage GB, Sostman HD, Brizel DM, Layfield L, Charles HC, Dewhirst MW, Prescott DM, Friedmann HS, Harrelson JM, Scully SP, Coleman RE: Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 37: 1438-1444, 1996.
12. Nieweg OE, Pruim J, van Ginkel RJ, Hoekstra HJ, Paans AMJ, Molenaar WM, Schraffordt Koops H, Vaalburg W: Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 37: 257-261, 1996.
13. F]Fluorodeoxyglucose. Ann Surg Oncol 4: 57-63, 1997.
14. Hudson TM, Schakel M, Springfield DS: Limitations of computed tomography following excisional biopsy of soft tissue sarcomas. Skeletal Radiol 13: 49-54, 1985.
15. Weekes RG, Berquist TH, McLeod RA, Zimmer WD: Magnetic resonance imaging of soft-tissue tumors: a comparison with computed tomography. Magn Reson Imaging 3: 345-352, 1985.
16. Reuther G, Mutschler W: Detection of local recurrent disease in musculoskeletal tumors: magnetic resonance imaging versus computed tomography. Skeletal Radiol 19: 85-90, 1990.
17. Pino G, Conzi GF, Murolo C, Schenone F, Magliani L, Imperiale A, Dato G, Panetta M, Toma S: Sonographic evaluation of local recurrences of soft tissue sarcomas. J Ultrasound Med 12: 23-26, 1993.
18. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14: 859-868, 1996.
19. 18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr 14: 486-487, 1990.
20. Meyer MA: Diffusely increased colonic F-18 FDG uptake in acute enterocolitis. Clin Nucl Med 20: 434-435, 1990.
21. 11C] alpha-aminoisobutyric acid (AIB), a potential radiotracer for imaging and amino acid transport studies in normal and malignant tissues. Int J Nucl Med Biol 11: 209-214, 1984.
22. Sordillo PP, DiResta GR, Fissekis J, Conti P, Benua RS, Yeh SD, Laughlin JS: Tumor imaging with carbon-11 labeled alpha-aminoisobutyric acid (AIB) in patients with malignant melanoma. Am J Physiol Imaging 6: 172-175, 1991.
23. Bigler RE, Zanzonico PB, Schmall B, Conti PS, Dahl JR, Rothman L, Sgouros G, MacEwen EG: Evaluation of [1-11HC]-alpha-aminoisobutyric acid for tumor detection and aminoacid transport measurements: spontaneous canine tumor studies. Eur J Nucl Med 10: 48-55, 1985.
24. Weiss SW: WHO. Histological typing of soft tissue tumors (ed 2). Berlin, Heidelberg, New York, Springer Verlag 1-86, 1994.
25. Hermanek P, Sobin LH (eds): UICC TNM classification of malignant tumors (ed 4, rev 2). Berlin Heidelberg New York, Springer 92-95, 1992.
26. Kontaxakis G, Tzanakos GS, Strauss LG, Dimitrakopoulou-Strauss A, Mantaka P, van Kaick G: Characteristics of the local convergence behavior of the iterative ML-EM image reconstruction algorithms. J Nucl Med 38: 202, 1997.
27. Schmidlin P, Kübier WK, Doll J: Image processing in whole-body positron emission tomography. In Schmidt HAE, Csernay L, eds. Nuclearmedizin. Stuttgart, Schattauer 84-87, 1987.
28. 18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-amino-pyridinium resin. Nucl Med Biol 3: 273-279, 1990.
29. Del Fiore F, Depresseux JC, Bartsch P, Quaglia L, Peters JM: Production of oxygen-15, nitrogen-13 and carbon-11 and of their low molecular weight derivatives for biomedical applications. Int J Appl Radiat Isot 30: 543-549, 1979.
30. Eary JF, Conrad EU, Bruckner JD, Flope A, Hunt KJ, Mankoff DA, Hewlett AT: Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 4: 1215-1220, 1998.
31. Arbeit JM, Hilaris BS, Brennan MF: Wound complications in the multimodality treatment of extremity and superficial truncal sarcomas. J Clin Oncol 5: 480-488, 1987.
32. Schmall B, Conti PS, Bigler RE, Zanzonico PB, Reiman RE, Benua RS, Yeh SD, Dahl JR, Lee R, Laughlin JS: Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB). Clin Nucl Med 1: 22-26, 1987.
33. Schwarzbach M, Lehnert T, Willeke F, Hinz U, Herfarth C: The results of isolated hyperthermic limb perfusion in a multimodality therapy concept for soft-tissue sarcoma. Chirurg 67: 1237-1243, 1996.
34. Higashi K, Clavo A, Wahl RL: Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 34: 414-419, 1993.